Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 12 studies | 21% ± 6% | |
endothelial cell of artery | 6 studies | 24% ± 5% | |
natural killer cell | 3 studies | 23% ± 9% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 25% ± 9% | |
mucosal invariant T cell | 3 studies | 25% ± 8% | |
CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
glutamatergic neuron | 3 studies | 22% ± 8% |
Insufficient scRNA-seq data for expression of SMAD7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3376.15 | 458 / 459 | 100% | 28.51 | 1114 / 1118 |
prostate | 100% | 2498.29 | 245 / 245 | 99% | 16.22 | 495 / 502 |
intestine | 100% | 2194.59 | 966 / 966 | 98% | 16.78 | 518 / 527 |
kidney | 100% | 2396.22 | 89 / 89 | 98% | 29.46 | 884 / 901 |
uterus | 100% | 2306.25 | 170 / 170 | 98% | 18.99 | 448 / 459 |
lung | 100% | 4176.02 | 577 / 578 | 97% | 18.36 | 1126 / 1155 |
stomach | 99% | 1509.03 | 354 / 359 | 98% | 17.13 | 281 / 286 |
thymus | 100% | 3991.12 | 653 / 653 | 96% | 31.99 | 582 / 605 |
bladder | 100% | 2685.10 | 21 / 21 | 94% | 16.07 | 475 / 504 |
esophagus | 96% | 1724.34 | 1381 / 1445 | 97% | 13.92 | 178 / 183 |
ovary | 98% | 1661.99 | 177 / 180 | 94% | 14.83 | 406 / 430 |
adrenal gland | 100% | 1349.16 | 257 / 258 | 93% | 17.16 | 214 / 230 |
brain | 93% | 1430.45 | 2452 / 2642 | 98% | 16.09 | 689 / 705 |
skin | 92% | 1510.38 | 1668 / 1809 | 88% | 12.03 | 416 / 472 |
pancreas | 54% | 483.60 | 176 / 328 | 98% | 23.33 | 175 / 178 |
liver | 85% | 1084.65 | 191 / 226 | 67% | 7.60 | 273 / 406 |
adipose | 100% | 3939.66 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10417.28 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.80 | 1 / 1 |
spleen | 99% | 1245.07 | 239 / 241 | 0% | 0 | 0 / 0 |
heart | 99% | 4984.07 | 850 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 17.05 | 44 / 45 |
muscle | 81% | 998.34 | 653 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 7.12 | 65 / 80 |
lymph node | 0% | 0 | 0 / 0 | 79% | 11.34 | 23 / 29 |
peripheral blood | 40% | 657.27 | 373 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030279 | Biological process | negative regulation of ossification |
GO_0048844 | Biological process | artery morphogenesis |
GO_0001657 | Biological process | ureteric bud development |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_2000317 | Biological process | negative regulation of T-helper 17 type immune response |
GO_0034333 | Biological process | adherens junction assembly |
GO_0002725 | Biological process | negative regulation of T cell cytokine production |
GO_0060392 | Biological process | negative regulation of SMAD protein signal transduction |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0010944 | Biological process | negative regulation of transcription by competitive promoter binding |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_0060373 | Biological process | regulation of ventricular cardiac muscle cell membrane depolarization |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032926 | Biological process | negative regulation of activin receptor signaling pathway |
GO_1903043 | Biological process | positive regulation of chondrocyte hypertrophy |
GO_0055010 | Biological process | ventricular cardiac muscle tissue morphogenesis |
GO_0010801 | Biological process | negative regulation of peptidyl-threonine phosphorylation |
GO_0060395 | Biological process | SMAD protein signal transduction |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_2000320 | Biological process | negative regulation of T-helper 17 cell differentiation |
GO_0010719 | Biological process | negative regulation of epithelial to mesenchymal transition |
GO_0030154 | Biological process | cell differentiation |
GO_0050821 | Biological process | protein stabilization |
GO_0060412 | Biological process | ventricular septum morphogenesis |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_1902731 | Biological process | negative regulation of chondrocyte proliferation |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0033137 | Biological process | negative regulation of peptidyl-serine phosphorylation |
GO_0034616 | Biological process | response to laminar fluid shear stress |
GO_0010717 | Biological process | regulation of epithelial to mesenchymal transition |
GO_0051444 | Biological process | negative regulation of ubiquitin-protein transferase activity |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0055117 | Biological process | regulation of cardiac muscle contraction |
GO_0031503 | Biological process | protein-containing complex localization |
GO_0022409 | Biological process | positive regulation of cell-cell adhesion |
GO_0005886 | Cellular component | plasma membrane |
GO_0005813 | Cellular component | centrosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001650 | Cellular component | fibrillar center |
GO_0005829 | Cellular component | cytosol |
GO_0005912 | Cellular component | adherens junction |
GO_0005737 | Cellular component | cytoplasm |
GO_0071144 | Cellular component | heteromeric SMAD protein complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0070697 | Molecular function | activin receptor binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0034713 | Molecular function | type I transforming growth factor beta receptor binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0070411 | Molecular function | I-SMAD binding |
GO_0005518 | Molecular function | collagen binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SMAD7 |
Protein name | SMAD family member 7 Mothers against decapentaplegic homolog 7 (MAD homolog 7) (Mothers against DPP homolog 7) (Mothers against decapentaplegic homolog 8) (MAD homolog 8) (Mothers against DPP homolog 8) (SMAD family member 7) (SMAD 7) (Smad7) (hSMAD7) |
Synonyms | MADH7 MADH8 |
Description | FUNCTION: Antagonist of signaling by TGF-beta (transforming growth factor) type 1 receptor superfamily members; has been shown to inhibit TGF-beta (Transforming growth factor) and activin signaling by associating with their receptors thus preventing SMAD2 access . Functions as an adapter to recruit SMURF2 to the TGF-beta receptor complex. Also acts by recruiting the PPP1R15A-PP1 complex to TGFBR1, which promotes its dephosphorylation. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator. . |
Accessions | ENST00000589634.1 [O15105-3] ENST00000586093.1 ENST00000262158.8 [O15105-1] O15105 ENST00000591805.5 [O15105-2] K7EKF0 |